Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide

Title
Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide
Authors
Keywords
-
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 86, Issue -, Pages S26-S34
Publisher
Elsevier BV
Online
2009-12-19
DOI
10.1016/s0168-8227(09)70006-3

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started